Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Shares Issued (2013 - 2024)

Pharma-Bio Serv posted quarterly Shares Issued of $1.0 for Q1 2024, down 80.0% on a QoQ basis from $5.0 in Q2 2023.

Pharma-Bio Serv (PBSV) has 5 years of Shares Issued data on file, last reported at $1.0 in Q1 2024.

  • For the quarter ending Q1 2024, Shares Issued changed N/A year-over-year to $1.0; the trailing twelve-month figure through Apr 2024 stood at $6.0 (down 25.0% YoY), and the FY2023 full-year result was $5.0, up 66.67% from the prior year.
  • Shares Issued for Q1 2024 stood at $1.0, down from $5.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $5.0 in Q2 2023 and bottomed at $1.0 in Q1 2024.
  • The 4-year median for Shares Issued is $2.5 (2021), against an average of $2.75.
  • Peak annual rise in Shares Issued reached 50.0% in 2022, while the deepest fall reached 50.0% in 2022.
  • A 4-year view of Shares Issued shows it stood at $2.0 in 2021, then surged by 50.0% to $3.0 in 2022, then jumped by 66.67% to $5.0 in 2023, then slumped by 80.0% to $1.0 in 2024.
  • The last three Shares Issued figures came in at $1.0 (Q1 2024), $5.0 (Q2 2023), and $3.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 13.87 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.09 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 418,000.00
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 410,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -3.13 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 2.41 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 273,000.00
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 774,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 7.76 Mn
10 Pharma-Bio Serv - - 722,374.00 -

Historic Data

Download Data 🔒
DateValue
Jan 31, 2024 1.00
Jan 31, 2024 1.00
Apr 30, 2023 5.00
Apr 30, 2023 5.00
Jan 31, 2022 3.00
Jan 31, 2022 3.00
Jan 31, 2021 2.00
Jan 31, 2021 2.00
Jan 31, 2013 109,859.00
Jan 31, 2013 109,859.00